SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-009627
Filing Date
2018-05-11
Accepted
2018-05-11 16:39:51
Documents
48
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q kmph20180331_10q.htm 10-Q 1180152
2 EXHIBIT 31.1 ex_111146.htm EX-31.1 14490
3 EXHIBIT 31.2 ex_111147.htm EX-31.2 14572
4 EXHIBIT 32.1 ex_111148.htm EX-32.1 7037
5 EXHIBIT 32.2 ex_111149.htm EX-32.2 7304
  Complete submission text file 0001437749-18-009627.txt   3735960

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kmph-20180331.xml EX-101.INS 594060
7 XBRL TAXONOMY EXTENSION SCHEMA kmph-20180331.xsd EX-101.SCH 34969
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kmph-20180331_cal.xml EX-101.CAL 25622
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kmph-20180331_def.xml EX-101.DEF 258153
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kmph-20180331_lab.xml EX-101.LAB 207616
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kmph-20180331_pre.xml EX-101.PRE 265447
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 18827464
SIC: 2834 Pharmaceutical Preparations